STEVENS CHRISTOPHER JAMES (Chief Operating Officer) sold 6.8% of their position (36.66K shares) of ROCKET PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $128.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/13/2026ACC: 0001140361-26-032818
Officer· Chief Operating Officer
Since Feb 2026
-36.66K
Net shares
Net seller
$128.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
36.66K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−36.66K
Price / share
$3.50
Trade value
$128.27K
% of position
6.8%
8/11/2026
542.44K→505.78K
Total
Net shares
−36.66K
Net value
-$128.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/11/2026 | S · Sale | −36.66K | $3.50 | $128.27K | 6.8% | 542.44K | 505.78K |
| Total | −36.66K | -$128.27K | ||||||
Derivative Transactions0
No derivative transactions reported